Liu J, Kharazmi E, Liang Q, Chen Y, Sundquist J, Sundquist K
Leukemia. 2025; 39(3):590-598.
PMID: 39865137
PMC: 11879861.
DOI: 10.1038/s41375-025-02517-6.
Chen R, Tang L, Melendy T, Yang L, Goodison S, Sun Y
Cancer Res Commun. 2024; 4(10):2783-2798.
PMID: 39347576
PMC: 11500312.
DOI: 10.1158/2767-9764.CRC-24-0210.
Zhou J, Li L, Zhang H, Agborbesong E, Harris P, Calvet J
Kidney Int. 2024; 106(2):258-272.
PMID: 38782200
PMC: 11270650.
DOI: 10.1016/j.kint.2024.04.017.
Tomazini A, Shifman J
Oncotarget. 2023; 14:672-687.
PMID: 37395750
PMC: 10317039.
DOI: 10.18632/oncotarget.28469.
Salla M, Guo J, Joshi H, Gordon M, Dooky H, Lai J
Int J Mol Sci. 2023; 24(6).
PMID: 36983040
PMC: 10055751.
DOI: 10.3390/ijms24065967.
Neuroinflammation regulates the balance between hippocampal neuron death and neurogenesis in an ex vivo model of thiamine deficiency.
Cassiano L, Oliveira M, Pioline J, Salim A, Coimbra R
J Neuroinflammation. 2022; 19(1):272.
PMID: 36376954
PMC: 9664832.
DOI: 10.1186/s12974-022-02624-6.
Regulation of GTPase function by autophosphorylation.
Johnson C, Seo H, Terrell E, Yang M, KleinJan F, Gebregiworgis T
Mol Cell. 2022; 82(5):950-968.e14.
PMID: 35202574
PMC: 8986090.
DOI: 10.1016/j.molcel.2022.02.011.
Prognostic Significance of Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer.
Tserpeli V, Stergiopoulou D, Londra D, Giannopoulou L, Buderath P, Balgkouranidou I
Cancers (Basel). 2022; 14(1).
PMID: 35008168
PMC: 8750111.
DOI: 10.3390/cancers14010004.
Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma.
Singh A, Erijman A, Noronha A, Kumar H, Peleg Y, Yarden Y
J Biol Chem. 2021; 297(6):101353.
PMID: 34717958
PMC: 8605244.
DOI: 10.1016/j.jbc.2021.101353.
Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1.
Yan H, Yu C, Fine S, Youssof A, Yang Y, Yan J
Oncogene. 2021; 40(50):6759-6771.
PMID: 34663879
PMC: 8688281.
DOI: 10.1038/s41388-021-02040-9.
Integrated genomics point to immune vulnerabilities in pleural mesothelioma.
Nastase A, Mandal A, Lu S, Anbunathan H, Morris-Rosendahl D, Zhi Zhang Y
Sci Rep. 2021; 11(1):19138.
PMID: 34580349
PMC: 8476593.
DOI: 10.1038/s41598-021-98414-w.
RASSF9 promotes NSCLC cell proliferation by activating the MEK/ERK axis.
Yuan J, Ju Q, Zhu J, Jiang Y, Yang X, Liu X
Cell Death Discov. 2021; 7(1):199.
PMID: 34341331
PMC: 8329231.
DOI: 10.1038/s41420-021-00583-0.
Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC).
Zhao P, Malik S, Xing S
Front Oncol. 2021; 11:677926.
PMID: 34336665
PMC: 8320331.
DOI: 10.3389/fonc.2021.677926.
Evidence of Cooperation between Hippo Pathway and Mutation in Thyroid Carcinomas.
Ribeiro Carneiro T, Bim L, Buzatto V, Galdeno V, Asprino P, Lee E
Cancers (Basel). 2021; 13(10).
PMID: 34065786
PMC: 8151534.
DOI: 10.3390/cancers13102306.
Detection of Endogenous RASSF1A Interacting Proteins.
Donninger H, Harrell-Stewart D, Clark G
Methods Mol Biol. 2021; 2262:303-310.
PMID: 33977485
DOI: 10.1007/978-1-0716-1190-6_18.
Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.
Borah N, Reddy M
Molecules. 2021; 26(7).
PMID: 33915740
PMC: 8037052.
DOI: 10.3390/molecules26071981.
Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview.
Akhlaghipour I, Bina A, Abbaszadegan M, Moghbeli M
Genes Environ. 2021; 43(1):14.
PMID: 33883026
PMC: 8059047.
DOI: 10.1186/s41021-021-00187-1.
The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis.
Zinatizadeh M, Miri S, Zarandi P, Chalbatani G, Raposo C, Mirzaei H
Genes Dis. 2021; 8(1):48-60.
PMID: 33569513
PMC: 7859453.
DOI: 10.1016/j.gendis.2019.11.003.
lncRNA TUSC7 inhibits osteosarcoma progression through the miR‑181a/RASSF6 axis.
Zhao A, Liu W, Cui X, Wang N, Wang Y, Sun L
Int J Mol Med. 2021; 47(2):583-594.
PMID: 33416181
PMC: 7797460.
DOI: 10.3892/ijmm.2020.4825.
Mechanisms of JAK-STAT signaling pathway mediated by CXCL8 gene silencing on epithelial-mesenchymal transition of human cutaneous melanoma cells.
Hu X, Yuan L, Ma T
Oncol Lett. 2020; 20(2):1973-1981.
PMID: 32724443
PMC: 7377181.
DOI: 10.3892/ol.2020.11706.